Structure Therapeutics Inc.
GPCR
$56.65
$2.905.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 190.47% | -93.40% | -136.85% | -79.88% | -48.88% |
| Total Depreciation and Amortization | 175.94% | 37.32% | 25.43% | 23.42% | 198.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1,643.21% | 1,497.68% | 158.42% | 1,292.63% | 877.78% |
| Change in Net Operating Assets | -17,471.72% | -30.58% | 251.57% | 16.74% | -119.63% |
| Cash from Operations | -76.64% | -158.92% | -106.71% | -53.25% | -67.83% |
| Capital Expenditure | -9,250.00% | -129.49% | 45.67% | -93.83% | 98.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 58.04% | 71.91% | 124.09% | 2,073.86% | 118.51% |
| Cash from Investing | 68.93% | 73.91% | 123.93% | 2,300.07% | 118.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 114,735.28% | 14,367.25% | -99.90% | 27.81% | -99.80% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 33.28% | -- | -- | 100.00% |
| Cash from Financing | 114,532.03% | 7,524.44% | -99.90% | 15.24% | -99.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26,692.02% | 78.94% | -101.80% | 45.60% | -103.31% |